Close Menu
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
Trending

Court Rules Alabama Violated Constitutional Rights of Man on Death Row

July 2, 2025

Lindsay Arnold’s Family Moments: A Heartwarming Album with Husband Sam Cusick and Daughters Sage and June

July 2, 2025

Commanders WR Seen With Trainer Amid Online Backlash

July 1, 2025
Facebook X (Twitter) Instagram
Smiley face Weather     Live Markets
  • Newsletter
  • Advertise
Facebook X (Twitter) Instagram YouTube
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
InfoQuest Network
  • News
  • World
  • Politics
  • Business
  • Finance
  • Entertainment
  • Health & Wellness
  • Lifestyle
  • Technology
  • Travel
  • Sports
  • Personal Finance
  • Billionaires
  • Crypto
  • Innovation
  • Investing
  • Markets
  • Startup
  • Immigration
  • Science
Home»Health & Wellness»Potential Benefits of Cannabis Pill for Agitation Reduction
Health & Wellness

Potential Benefits of Cannabis Pill for Agitation Reduction

News RoomBy News RoomOctober 9, 20240 ViewsNo Comments3 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email Reddit Telegram WhatsApp

Agitation is a common issue experienced by individuals with Alzheimer’s disease, making daily life and care challenging. Researchers are interested in finding effective ways to manage agitation, including the use of medications. One recent study focused on dronabinol, derived from cannabis, as a potential treatment for reducing agitation in individuals with Alzheimer’s disease. The study involved 75 participants over three weeks and found that dronabinol was more effective at reducing agitation compared to a placebo, without significantly increasing the risk of adverse events. These findings suggest that dronabinol may be a useful option for managing agitation in clinical practice in the future.

Alzheimer’s disease is a complex condition involving memory loss, changes in learning abilities, and behavioral changes. Diagnosing Alzheimer’s disease can be challenging, as there is no single test available for definitive diagnosis. Biomarkers related to Alzheimer’s disease in blood may change based on the time of day, adding another layer of complexity to the diagnostic process. After receiving a diagnosis of Alzheimer’s disease, it is important for individuals to work together to develop effective management strategies for addressing symptoms and improving quality of life.

Agitation is a common symptom associated with Alzheimer’s disease that can lead to challenging behaviors such as resisting care, trouble sleeping, and combativeness. While behavioral strategies are commonly used to manage agitation, medication can also play a role in treatment. The use of dronabinol, a synthetic version of THC, was explored in a recent study as a potential treatment for reducing agitation symptoms in individuals with Alzheimer’s disease. The study involved 75 participants over a three-week period and found that dronabinol was effective at reducing agitation compared to a placebo, with no significant differences in adverse events between the two groups.

Kangen Water

Despite the promising results of the study, there are limitations that need to be considered. The full study has not yet been published for public review, and the sample size of 75 participants is relatively small. The short intervention period of three weeks also limits the ability to assess long-term effects of dronabinol. Participants in both groups were receiving other antipsychotic and antidepressant treatments, which could have influenced the results. Future research with larger sample sizes and longer intervention periods may help to confirm the findings and evaluate the potential benefits of dronabinol in clinical practice for managing agitation in individuals with Alzheimer’s disease.

While dronabinol showed promise in reducing agitation symptoms in individuals with Alzheimer’s disease, it is important to note that this treatment is symptomatic and does not address the underlying causes of the disease. Similar symptomatic treatments already exist, and dronabinol carries its own risks. Continued research is needed to determine the long-term effectiveness of dronabinol and to explore other cannabis products available at dispensaries for potential use in managing agitation. Future studies should also consider including a more diverse participant population to ensure the generalizability of the findings and address potential gender disparities in research outcomes.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related News

Steven Alderson Makes History as First Golfer with Autism to Win G4D Tour Event

October 17, 2024

Cause of Death for Liam Payne Uncovered in Autopsy Report

October 17, 2024

Ananda Lewis of MTV Shares Her Experience with Breast Cancer Diagnosis and Treatment

October 17, 2024

Practicing mindfulness could be just as beneficial as taking an antidepressant

October 17, 2024

The impact of caffeine on disease risk: A closer look

October 17, 2024

Serena Williams discloses removal of grapefruit-sized cyst from her neck

October 16, 2024
Add A Comment
Leave A Reply Cancel Reply

Top News

Lindsay Arnold’s Family Moments: A Heartwarming Album with Husband Sam Cusick and Daughters Sage and June

July 2, 2025

Commanders WR Seen With Trainer Amid Online Backlash

July 1, 2025

Paramount to Compensate Trump $16 Million to Resolve ’60 Minutes’ Lawsuit

July 1, 2025

Subscribe to Updates

Get the latest news and updates directly to your inbox.

Advertisement
Kangen Water
InfoQuest Network
Facebook X (Twitter) Instagram YouTube
  • Home
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Info Quest Network. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.